Contents

CNS & Neurological Disorders - Drug Targets , Volume 6 - Number 4

Editorial [ Migraine Guest Editor: Dimos D. Mitsikostas ]

, 6(4): 234

Dimos D. Mitsikostas


DOI: 10.2174/187152707781387332




5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines

, 6(4): 235 - 237

Reto M. Agosti


DOI: 10.2174/187152707781387242




Pathophysiology of Tension-Type Headache: Potential Drug Targets

, 6(4): 238 - 239

Messoud Ashina


DOI: 10.2174/187152707781387297




CGRP-Receptor Antagonism in Migraine Treatment

, 6(4): 240 - 246

Lars Edvinsson and Kenneth Ahrend Petersen


DOI: 10.2174/187152707781387314




GABAergic Drugs for the Treatment of Migraine

, 6(4): 247 - 250

Anja Puppe and Volker Limmroth


DOI: 10.2174/187152707781387305




The Role of Glutamate and its Receptors in Migraine

, 6(4): 251 - 257

Michail Vikelis and Dimos D. Mitsikostas


DOI: 10.2174/187152707781387279




Nitric Oxide in Migraine

, 6(4): 258 - 264

L. Neeb and U. Reuter


DOI: 10.2174/187152707781387233




Novel Targets for Drugs in Schizophrenia

, 6(4): 265 - 272

J.M. Stone and L.S. Pilowsky


DOI: 10.2174/187152707781387323




Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease

, 6(4): 273 - 281

Liang-Wei Chen, Yan-Qin Wang, Li-Chun Wei, Mei Shi and Ying-Shing Chan


DOI: 10.2174/187152707781387288




Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases

, 6(4): 282 - 287

Christian Schmeer, Alexandra Kretz and Stefan Isenmann


DOI: 10.2174/187152707781387260




Extrasynaptic GABA and Glutamate Receptors in Epilepsy

, 6(4): 288 - 300

German Sierra-Paredes and German Sierra-Marcuno


DOI: 10.2174/187152707781387251




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science